PODESTA GROUP, INC. for EISAI INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Financial Institutions/Investments/Securities FIN
Student Loan Auction Rate Securities (SLARS) H.R. 3081 Continuing Appropriations Act, 2011 (SLARS Provisions) H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) 1)H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | — |
| SHARON COHEN | — |
| LAUREN MADDOX | — |
Pharmacy PHA
S. 726 Promoting Innovation and Access to Life-Saving Medicine Act P.L. 111-148 Patient Protection and Affordable Care Act implementation P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | — |
| SHARON COHEN | — |
| THOMAS B SPARKMAN | — |
Health Issues HCR
Health Reform, Comparative Effectiveness, Alzheimer's Awareness, Alzheimer's Issues P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| THOMAS B SPARKMAN | — |
Medicare/Medicaid MMM
P.L. 111-148 Patient Protection and Affordable Care Act implementation P.L. 111-152 Health Care and Education Reconciliation Act of 2010 implementation H.R. 4899 Supplemental Appropriations Act, 2010 (AMP Revisions) H.R. 3081 Continuing Appropriations Act, 2011 (340B Provisions) H.R. 5712 Veterans', Seniors', and Children's Health Technical Corrections Act of 2010 (340B Orphan Drug Childrens rovision) S. 11 To restore the application of the 340B drug discount program to orphan drugs with respect to childrens hospitals H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290H.R. 4994, Medicare and Medicaid Extenders Act of 2010; P.L. 111-309 H.R. 5712, The Physician Payment and Therapy Relief Act of 2010; P.L. 111-286
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| THOMAS B SPARKMAN | — |
Education EDU
Student Loan Auction Rate Securities H.R. 3081 Continuing Appropriations Act, 2011 H.R. 4899 Supplemental Appropriations Act, 2010 H.R. 3082, Continuing Appropriations and Surface Transportation Extensions Act, 2011; PL 111-322 H.J.RES.105, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-317 H.J.RES.101, Making further continuing appropriations for fiscal year 2011, and for other purposes; PL 111-290
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | — |
| SHARON COHEN | — |
| LAUREN MADDOX | — |
Copyright/Patent/Trademark CPT
Patent Reform H.R. 1260 Patent Reform Act of 2009 S. 515 Patent Reform Act of 2009 S. 610 Patent Reform Act of 2009
Foreign entity interest: Eisai Co., Ltd. to the degree that public policies, either laws or regulations, commercially benefit Eisai, Inc., so too Eisai Co., Ltd., as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SHARON COHEN | — |
| THOMAS B SPARKMAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.